168 related articles for article (PubMed ID: 37608090)
1. Bladder pain syndrome and sexual function: a systematic review and meta-analysis.
Sobti A; Shawer S; Ballard P; Khunda A
Int Urogynecol J; 2023 Oct; 34(10):2359-2371. PubMed ID: 37608090
[TBL] [Abstract][Full Text] [Related]
2. Sexual dysfunction in women with interstitial cystitis/bladder pain syndrome: Do onabotulinum toxin-A injections improve sexual function?
Topcuoglu M; Karaburun MC; İbiş A; Gokce Mİ; Süer E; Gülpinar O
Neurourol Urodyn; 2023 Mar; 42(3):607-614. PubMed ID: 36708358
[TBL] [Abstract][Full Text] [Related]
3. Interstitial Cystitis/Bladder Pain Syndrome Treatment: A Systematic Review of Sexual Health Outcomes.
Chen A; Shahiyan RH; Anger JT
Sex Med Rev; 2022 Jan; 10(1):71-76. PubMed ID: 34219009
[TBL] [Abstract][Full Text] [Related]
4. Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution.
Hung MJ; Su TH; Lin YH; Huang WC; Lin TY; Hsu CS; Chuang FC; Tsai CP; Shen PS; Chen GD
J Sex Med; 2014 Sep; 11(9):2256-63. PubMed ID: 24636240
[TBL] [Abstract][Full Text] [Related]
5. Sexual dysfunction in women with interstitial cystitis/bladder pain syndrome: A case-control study.
Agrawal A; Tripathy S; Kumar D
Indian J Urol; 2020; 36(3):212-215. PubMed ID: 33082637
[TBL] [Abstract][Full Text] [Related]
6. Examining vaginal and vulvar health and sexual dysfunction in patients with interstitial cystitis (UNICORN-1 study).
Okui N; Okui M; Gambacciani M
Int Urogynecol J; 2022 Sep; 33(9):2493-2499. PubMed ID: 35543734
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of intravesical chondroitin-sulfate and combined hyaluronic-acid/chondroitin-sulfate therapy on female sexual function in bladder pain syndrome.
Arslan B; Gönültaş S; Gökmen E; Özman O; Avci MA; Özdemir E
Int Urogynecol J; 2019 Nov; 30(11):1857-1862. PubMed ID: 31254047
[TBL] [Abstract][Full Text] [Related]
8. Pentosan polysulfate in patients with bladder pain syndrome/interstitial cystitis with Hunner's lesions or glomerulations: systematic review and meta-analysis.
Grigoryan B; Kasyan G; Pivazyan L; Pushkar D
Ther Adv Urol; 2022; 14():17562872221102809. PubMed ID: 35677571
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and correlates of sexual dysfunction among women with bladder pain syndrome/interstitial cystitis.
Bogart LM; Suttorp MJ; Elliott MN; Clemens JQ; Berry SH
Urology; 2011 Mar; 77(3):576-80. PubMed ID: 21215432
[TBL] [Abstract][Full Text] [Related]
10. Sexual Dysfunction in Interstitial Cystitis.
Tonyali S; Yilmaz M
Curr Urol; 2017 Nov; 11(1):1-3. PubMed ID: 29463969
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Impact of intravesical onabotulinumtoxinA (Botox) on sexual function in patients with overactive bladder syndrome: a systematic review and meta-analysis.
Shawer S; Khunda A; Waring GJ; Ballard P
Int Urogynecol J; 2022 Feb; 33(2):235-243. PubMed ID: 35024885
[TBL] [Abstract][Full Text] [Related]
13. Intravesical Botulinum Toxin A Injections for Bladder Pain Syndrome/Interstitial Cystitis: A Systematic Review and Meta-Analysis of Controlled Studies.
Wang J; Wang Q; Wu Q; Chen Y; Wu P
Med Sci Monit; 2016 Sep; 22():3257-67. PubMed ID: 27624897
[TBL] [Abstract][Full Text] [Related]
14. Botulinum Neurotoxin A Intravesical Injections in Interstitial Cystitis/Bladder Painful Syndrome: A Systematic Review with Meta-Analysis.
Giannantoni A; Gubbiotti M; Bini V
Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31480323
[TBL] [Abstract][Full Text] [Related]
15. Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment.
Liang CC; Lin YH; Hsieh WC; Huang L
Taiwan J Obstet Gynecol; 2018 Jun; 57(3):360-363. PubMed ID: 29880165
[TBL] [Abstract][Full Text] [Related]
16. Use of Intravesical Injections of Platelet-Rich Plasma for the Treatment of Bladder Pain Syndrome: A Comprehensive Literature Review.
Trama F; Illiano E; Marchesi A; Brancorsini S; Crocetto F; Pandolfo SD; Zucchi A; Costantini E
Antibiotics (Basel); 2021 Oct; 10(10):. PubMed ID: 34680774
[TBL] [Abstract][Full Text] [Related]
17. Adding a sexual dysfunction domain to UPOINT system improves association with symptoms in women with interstitial cystitis and bladder pain syndrome.
Liu B; Su M; Zhan H; Yang F; Li W; Zhou X
Urology; 2014 Dec; 84(6):1308-13. PubMed ID: 25312548
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
Shie JH; Liu HT; Wang YS; Kuo HC
BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
[TBL] [Abstract][Full Text] [Related]
19. A Novel Intravesical Dextrose Injection Improves Lower Urinary Tract Symptoms on Interstitial Cystitis/Bladder Pain Syndrome.
Chen CL; Kao CC; Yang MH; Fan GY; Cherng JH; Tsao CW; Wu ST; Cha TL; Meng E
Front Pharmacol; 2021; 12():755615. PubMed ID: 34975473
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of botulinum toxin injection for interstitial cystitis/bladder pain syndrome: a systematic review and meta-analysis.
Shim SR; Cho YJ; Shin IS; Kim JH
Int Urol Nephrol; 2016 Aug; 48(8):1215-1227. PubMed ID: 27139498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
